Literature DB >> 8098997

Normal genetic variation at the low density lipoprotein receptor (LDLR) locus influences cholesterol levels in children.

R Poledne1, Z Pisa, K Berg.   

Abstract

The population of Czechoslovakia is at high risk of premature atherosclerosis. Normal DNA polymorphism at the low density lipoprotein receptor (LDLR) locus detectable with the restriction enzyme PvuII was analyzed in Czech children with a high or a low concentration of total serum cholesterol. The PvuII restriction site was found significantly more often in the low cholesterol group than in the high cholesterol group. Thus, normal genetic variation at the LDLR locus contributes to the population variation in cholesterol in children in the population studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098997     DOI: 10.1111/j.1399-0004.1993.tb04435.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease.

Authors:  L A Salazar; M H Hirata; S D Giannini; N Forti; J Diament; J S Issa; R D Hirata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study.

Authors:  Hind Muallem; Kari E North; Masao Kakoki; Mary K Wojczynski; Xia Li; Megan Grove; Eric Boerwinkle; Kirk C Wilhelmsen; Gerardo Heiss; Nobuyo Maeda
Journal:  Hum Genet       Date:  2007-02-02       Impact factor: 4.132

3.  European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.

Authors:  H Schuster; S Humphries
Journal:  Clin Investig       Date:  1994-11

4.  Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics.

Authors:  Youssef Tahiri; Fredrik Karpe; Garry D Tan; Katherine Cianflone
Journal:  Nutr Metab (Lond)       Date:  2007-05-09       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.